Medical device firm NeuroOne plots path to the Nasdaq with $12.5M private placement

It will spend the money on launching a second commercial product and potentially uplisting its stock from over-the-counter to the Nasdaq.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.